Henri Beaufour

CEO, Ipsen

Real-Time Net Worth

$3.4B

As of December 2025

Age

Source

Pharmaceuticals

Industry

healthcare

Citizenship

Biography

Henri Beaufour, a French businessman and billionaire, owes his fortune to his stake in Ipsen, a leading French pharmaceutical company. As a key figure in the healthcare industry, he is known for his involvement in Ipsen, a company founded by his grandfather. Henri, born in January 1965, inherited a significant portion of the family wealth after his father's passing. His career has been marked by his success in the pharmaceutical industry and his support of various charitable causes. He holds a bachelor's degree from Georgetown University and currently resides in London, United Kingdom. His current net worth is estimated at $3.4 Billion. Henri is also known for his philanthropic efforts in healthcare, education, and social welfare.

Wealth Over Time

Portfolio Holdings

Ipsen

IPN (Euronext)•healthcare

Information not found

Information not found employees

Founded 1929

In-Depth Profile

Early Life

Henri Pierre Albert Marie Beaufour was born on January 6, 1965, in Neuilly-sur-Seine, France. He is the son of Albert Beaufour and the grandson of Dr. Henri Beaufour, who founded the Ipsen Group, a global pharmaceutical company. Henri holds a bachelor's of arts degree from Georgetown University. He comes from a prominent French family with a long history in the pharmaceutical industry.

Rise to Success

Henri Beaufour began his career in the pharmaceutical industry after graduating from Georgetown University. In 2000, following the death of his father, Henri inherited 76% of the family's capital in Ipsen, making him the majority shareholder. He and his sister Anne now control about 52% of Ipsen. Under his leadership, Ipsen has experienced significant growth, becoming a leading player in the pharmaceutical industry.

Key Business Strategies

Henri Beaufour is primarily associated with Ipsen Group. Under his leadership, the company has expanded its global reach and developed innovative drugs. He is credited with diversifying Ipsen's portfolio and driving its growth in key therapeutic areas.

Philanthropy

Henri Beaufour is known for his philanthropic efforts and support of various charitable causes. He is actively involved in initiatives related to healthcare, education, and social welfare.

Career Milestones

2000

Inherited control of Ipsen

After his father's death, Henri inherited a significant portion of the family's capital in Ipsen, making him the majority shareholder.

Philanthropy & Social Impact

Education

Alasol Foundation

Undisclosed

A public interest foundation created by Mr. Beaufour to promote education, school and vocational training for disadvantaged children and young adults.